The National Institute for Health and Care Excellence (NICE) identified treatment of moderate-to-severe psoriasis as an area for research.(1-2) No recent studies have assessed treatment patterns and outcomes among patients hospitalised for psoriasis in the UK.(3-5) This study evaluated clinician- and patient-reported outcomes, treatment patterns, and hospital length of stay (LOS) in patients admitted to hospital for plaque or erythrodermic psoriasis, and enrolled 61 eligible patients across 9 UK hospital sites from 15 November 2013 to 2 June 2014. This article is protected by copyright. All rights reserved.